3.21
Cardiff Oncology Inc (CRDF) 最新ニュース
Equities Analysts Issue Forecasts for CRDF Q4 Earnings - Defense World
Can Cardiff Oncology Inc. stock double in next 5 yearsDividend Growth Stocks & Today’s Picks, Tomorrow’s Winners - ulpravda.ru
What is Noble Financial’s Estimate for CRDF FY2025 Earnings? - Defense World
Analysts Offer Predictions for CRDF FY2025 Earnings - MarketBeat
Cardiff Oncology stock initiated with Outperform rating by Noble Capital - Investing.com Australia
Noble Financial Initiates Coverage on Cardiff Oncology (NASDAQ:CRDF) - MarketBeat
Cardiff Oncology Inc. (CRDF) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Investors Purchase High Volume of Call Options on Cardiff Oncology (NASDAQ:CRDF) - Defense World
Cardiff Oncology (FRA:XE7C) EV-to-OCF : -3.04 (As of Dec. 24, 2025) - GuruFocus
Stock Traders Purchase High Volume of Cardiff Oncology Call Options (NASDAQ:CRDF) - MarketBeat
Flputnam Investment Management Co. Purchases 543,370 Shares of Cardiff Oncology, Inc. $CRDF - MarketBeat
Why analysts raise outlook for Cardiff Oncology Inc. (XE7C) stockTrade Analysis Report & Precise Swing Trade Entry Alerts - Улправда
3 Penny Stocks With At Least $100M Market Cap - simplywall.st
Short Covering: How analysts revise price targets for ConAgra Brands Inc stockPrice Action & Low Risk Profit Maximizing Plans - moha.gov.vn
Cardiff Oncology Earnings Notes - Trefis
Will Cardiff Oncology Inc. stock benefit from green energy trendsQuarterly Portfolio Summary & Verified Technical Trade Signals - Улправда
Quarterly Earnings: Will SIFYR stock continue dividend increasesMarket Activity Summary & AI Forecasted Entry and Exit Points - moha.gov.vn
Is Cardiff Oncology Inc. stock affected by interest rate hikesWeekly Profit Summary & Weekly Breakout Watchlists - Улправда
Cardiff Oncology, Inc. (NASDAQ:CRDF) Receives $10.83 Average Price Target from Analysts - Defense World
Published on: 2025-12-20 05:10:29 - Улправда
Institution Moves: Will Cardiff Oncology Inc. stock benefit from green energy trendsCPI Data & Daily Profit Focused Screening - Улправда
Aug Spikes: Is Cardiff Oncology Inc. stock affected by interest rate hikes2025 Retail Activity & Safe Swing Trade Setup Alerts - Улправда
Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com
Cardiff Oncology (STU:XE7C) EV-to-FCF : -2.30 (As of Dec. 18, 2025) - GuruFocus
Can Cardiff Oncology Inc. stock sustain revenue growthJuly 2025 Momentum & Consistent Return Investment Signals - Улправда
Cardiff Oncology, Inc. (NASDAQ:CRDF) Given Average Rating of "Hold" by Brokerages - MarketBeat
Operating cash flow per share of Cardiff Oncology, Inc. – LSX:A2P4GU - TradingView — Track All Markets
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era - The Manila Times
Zacks Small Cap Weighs in on CRDF FY2025 Earnings - Defense World
What drives Cardiff Oncology Inc stock priceSmall Cap Stock Opportunities & Free Daily Stock Hotspot Analysis - earlytimes.in
Cardiff Oncology CRDF US - Smartkarma
FY2025 Earnings Forecast for CRDF Issued By Zacks Small Cap - MarketBeat
A new trading data show Cardiff Oncology Inc (CRDF) is showing positive returns. - setenews.com
Institutions profited after Cardiff Oncology, Inc.'s (NASDAQ:CRDF) market cap rose US$19m last week but retail investors profited the most - Yahoo Finance
CRDF: Initiating Coverage – Combination Therapy Elicits Superior Response - Zacks Small Cap Research
Cardiff Presents Phase 1 Data Of Onvensertib In Chronic Myelomonocytic Leukemia At ASH 2025 - Nasdaq
Cardiff oncology reports positive results for onvansertib in leukemia trial - Investing.com
Cardiff oncology reports positive results for onvansertib in leukemia trial By Investing.com - Investing.com India
Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 - The Manila Times
Cardiff Oncology Announces Clinical Data from - One News Page
Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference - The Manila Times
Is Cardiff Oncology Inc. stock a contrarian buy2025 Key Highlights & Technical Pattern Based Signals - Newser
How Cardiff Oncology Inc. (XE7C) stock stacks up against competitorsMarket Risk Report & Low Volatility Stock Recommendations - Newser
Will Cardiff Oncology Inc. (XE7C) stock announce a stock splitAnalyst Upgrade & Technical Pattern Based Signals - Newser
Can Cardiff Oncology Inc. (XE7C) stock stage a strong rebound this quarter2025 Year in Review & High Accuracy Trade Alerts - Newser
大文字化:
|
ボリューム (24 時間):